Short Interest in NanoVibronix, Inc. (NASDAQ:NAOV) Expands By 113.2%

NanoVibronix, Inc. (NASDAQ:NAOV) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 82,500 shares, an increase of 113.2% from the March 15th total of 38,700 shares. Based on an average daily trading volume, of 2,430,000 shares, the days-to-cover ratio is presently 0.0 days. Approximately 13.0% of the shares of the company are sold short.

NanoVibronix Stock Down 2.5 %

NAOV opened at $7.16 on Friday. The stock has a market cap of $5.43 million, a price-to-earnings ratio of -5.82 and a beta of 1.84. NanoVibronix has a 12-month low of $1.92 and a 12-month high of $16.25. The business has a 50 day moving average of $4.44 and a 200-day moving average of $5.72.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.